About the course
Good Distribution Practices (GDP) is that area of quality assurance that ensures that pharmaceutical and nutrition products are consistently stored, transported, and handled under the temperature conditions defined for the product.
Workshop Objective
The objective of the training is to introduce Good Distribution Practices (GDP) for pharmaceutical and nutrition products and their main requirements with regards to UNICEF supply activities.
Learning Objectives
At the end of the course, participants will be able to:
- Describe the basic requirements of Good Distribution Practices for pharmaceutical and nutrition products;
- Interpret the requirements of Good Distribution Practices as outlined in the relevant guidelines;
- Recognize how Good Distribution Practices are applied during warehousing (and transportation) in relation to the supply activities at UNICEF. Note: focus will be given to the storage of pharmaceutical and nutrition products
Target Audience
Supply & Logistics staff from country offices who are involved in the storage of pharmaceutical and nutrition products, who are not familiar with the principles of Good Distribution Practice or wish to enhance their understanding.
Methodology
- This is an interactive virtual training via Microsoft Teams that combines presentations with practical exercises.
- The training consists of 2 sessions of 4 hours each, with a total of 8 hours. Participants are expected to fully attend both sessions and actively participate during the sessions.
- In preparation for the training, participants are requested to read the guidance Good storage and distribution practices for medical products
- At the end of the training, there is a short test (15 minutes) and a passing grade is required in order to obtain a course certificate.
Pre-workshop Tasks
(Please read the above document. You can also find it on Background Materials) Please read the guidelines "Good storage and distribution practices for medical products" in the link. (Reference: WHO Technical Report Series, No. 1025, 2020 Annex 7).